Corcel Share Discussion Threads

[bambos22] 10/3/2022 16:50

Bunch of numpties on here... Great news today. Very encouraging

[richie666] 10/3/2022 16:17

Bmcb - u mean £20k starting share cap to a £10m book in last 6 yrs? I guess that creates enemies & breeds jealousy. U are right.

[mrzippo] 10/3/2022 15:57

"Su su su su su sudio"Not my words. But those of the great Phil Collins. His analysis has stood the test of time.

[bmcb5] 10/3/2022 15:41

Not surprising at all, when you look at your track record

[richie666] 10/3/2022 15:21

The sheer magnitude of malice here to me/Align/Corcel is truly something to behold albeit not surprising.

Lurker - await the legal missive. As for 'bale' its bail & a cursory look at our accounts will highlight more of your Defamation. We most certainly were not 'baled' (or indeed bailed out last yr). We in fact made serious profits last yr (and continue to do so) & the gross value of our stakes in many companies now approaches £10m now.

Keep digging your hole...

[bmcb5] 10/3/2022 15:10

Always handy to be able to do an analysis with the priviliges of another super user, i guess.

Or maybe he meant something else

[kemche] 10/3/2022 15:01

"sudo analysis"???

[mrzippo] 10/3/2022 12:42

Hey Am not just anti Align, I'm anti Corcel too. This suits me fine.

[arlington chetwynd talbott] 10/3/2022 12:15

Maybe take the Align stuff to a dedicated "We hate Align" thread though? The rest of us would prefer the discussion to be about the balance of risk and reward at a £6M MCAP for CRCL - that's what it should be about.

[helpfull] 10/3/2022 11:56

That must have been at the turn of the century. Aero is now 60p. Same as a Crunchie.

Be careful.

[kemche] 10/3/2022 11:52

I crossed swords with him at AERO where he bested me. All the way from 10p to 0.01p.

QBA, PFP, AERO, ......

Always manages to find the finest companies and not utter POS ones.

Go on - Pharmacal that!

[lurker5] 10/3/2022 11:52

I see that Jennings doesn't rely on readers making up their own minds - and taking in whatever other opinions there might be out there - but tries to close them down. I suggest he looks up the rules re press freedom (and these boards are akin to a free press) to comment on anything related to investment. And here and now I ask him to explain why it was that Align, last year (its sll on Companie House) had to be baled out by one of the 'clients' it writes 'research' on, for losses it had made on its own 'conviction' stocks. In the interests of justice, I suspect a court will require Align to fully publish which of its own recommendations had led to its own losses. That will help protect the investing public.

[lurker5] 10/3/2022 11:40

Don't put him off. Align deserves to be outed in a public - preferably legal - forum for the self-interested and often biased 'recommendations' it makes in order to lure inexperienced investors into shares it has itself bought. As clear a case of market manipulation as you can find.

[helpfull] 10/3/2022 11:30

"You agree that in entering into this agreement you are over the age of 18 and you will at all times be acting as a Private Investor and not in the course of any employment, trade or profession which you may carry on. ADVFN reserve the right to retroactively apply professional subscription charges to your account if given sufficient reason to doubt your Private Investor status"

[kemche] 10/3/2022 11:24

He once threatened to Pharmacal me. I cried I can tell you. Not that he cares.

[arlington chetwynd talbott] 10/3/2022 11:09

Bit of an empty threat richie666. lurker5 may be missing the point of the AIM Game, but are his opinions really actionable? Are you seriously telling us that you have legal advice that they are? Maybe you should get a second opinion. Align produce what is in many ways arguably marketing material so, like most of these outfits, they offer a big, easy target and just have to take it when they get called out on it.

[helpfull] 10/3/2022 11:07

richie666 are you Richard Stephen Jennings as described in Companies House, the owner of Align Research, as you write in your post? Are you posting as a private investor, as you would have had to confirm such, when registering with ADVFN (the home of the private investor)? Or are you posting as an interested party directly connected to Corcel? I wonder if there are any rules or laws being broken here?

There is an interesting conflict. Corcel are paying you for "research" so that shareholders may be informed and you are labelling shareholders who don't agree with or question that research as "trolls".

Be careful.

[kemche] 10/3/2022 10:53

Richie playing the Pharmacall card again I see.

"and look to cost them materially financially for the damage they cause" - chutzpah right there!

[lurker5] 10/3/2022 10:37

Go ahead Mr Jennings. I look forward to outing your analyst's incompetence.

[lurker5] 10/3/2022 10:36

PS Re the vital question what is the real rate of reurn on the capex of each peaker plant and hence the cover for funding and what is the 'real' income left over for the company - I omittted that Tring is only 40% owned, so the £55m Kaintz wants (the first we've heard of it !) is for 70MW and probably represents no more than 75% of the true capital cost - which therefore works out at £1m per MW (which is in the right ball-park acc to other estimates I've found. For Tring Kaintz said 'gross margin' is estimated at £103,000-£147,000 per MW pa. Taking the top figure means 'gross return' (before other costs, tax, HQ, etc ?) of 14.7% which is probably just OK against a likely 8-9% loan interest rate. but repayment over the usual 9 years will be about 12-13% of the loan per annum , leaving only a tiny 2-3% pa cash surplus for Corcel before other costs. Which is why the cos and Align's 'revenues' are so misleading.- and omits that the co is going to have to find the other 25% of the capex. So rather than the peakers providing cash for expansion, the likelyhood is shareholders are going to have to cough up every time.

[richie666] 10/3/2022 09:45

Juat so parties are aware here - "lurker5" clearly has an agenda against Align and Cor cel. We have taken screenshots of all his defamatory posts and a legal process called a Norwich Pharmacal Order is in process to discover his true identity.

As the owner of Align I can assure all shareholders we will bring to a halt these trolls and look to cost them materially financially for the damage they cause and malice (and which incidentally in Defamation Law gives rise to aggravated damages).

[lurker5] 10/3/2022 09:40

I'm not aware we've ever been told what 'the base case' is or what capex is required - even for a DSO ? The fact is that development up to the point where a feasibility study to a standard required by any funder to take the project further will itself cost a multiple of CRCL's current market cap. Investing in these early stage prospects is always detrimental to a share price. And if the offtakers come up with (some) funds up front, they are always very expensive for current shareholders.
I suspect the cos idea was that the (imaginary) 'income' from the peakers would fund the nickel development - hence the importance of highlighting Align's nonsenses on that score.

[arlington chetwynd talbott] 10/3/2022 09:05

There are other things in the RNS, of course, but the relevant passage is:"The Company notes the suspension in nickel market trading at the London Metal Exchange ("LME") following a 250% surge in prices over 7-8 March, with intraday trading of over $100,000 per ton on Tuesday 8 of March.The Company has historically utilized a $18,500/t price assumption in the Company's base case modelling at its nickel projects in PNG. The Company therefore sees significant additional core net asset value from its upstream Battery Metal portfolio and anticipates that ongoing turmoil and extended volatility in global nickel markets will significantly enhance the business case for taking both Mambare and Wowo Gap into DSO production."Seems reasonable to highlight developments that suggest that their base case price assumption could well turn out to have been too conservative. The price could of course gap back down to, say, $25,000/t, but do you not think that the 2022 average price is now likely to be significantly higher than the base case price assumption? We are paying these guys to do a bit of share promotion, so this all seems entirely reasonable to me.